Literature DB >> 11422470

Correlation between Helicobacter pylori infection, gastric inflammation and serum homocysteine concentration.

W K Leung1, P K Ma, P C Choi, J Y Ching, A C Ng, P Poon, K S Woo, J J Sung.   

Abstract

BACKGROUND: Epidemiological studies have suggested a link between chronic Helicobacter pylori infection and ischemic heart disease but the underlying mechanism remains elusive. We hypothesized that H. pylori-associated chronic gastritis causes impairment of absorption of vitamin cofactors that are essential in the metabolism of homocysteine and results in hyperhomocysteinemia.
MATERIALS AND METHODS: Forty-nine dyspeptic patients were studied. H. pylori infection was defined by rapid urease test and histology. Fasting serum homocysteine level, which was measured by a validated commercial fluorescence polarization immunoassay, was correlated with H. pylori infection statuses and gastric histology. H. pylori-infected patients were followed up for 24 weeks post eradication for changes in serum homocysteine concentration.
RESULTS: Univariate analyses showed that serum homocysteine level correlated with increasing age (p <.001), male sex (p =.003) and smoking habit (p =.025). There was no significant difference in serum homocysteine levels between H. pylori infected and uninfected subjects (median 10.5 vs. 10.2 micromol/l). After successful eradication of the bacterium, there was no significant reduction in homocysteine level. Moreover, there was no correlation between homocysteine level and gastric histology including H. pylori density, activity and inflammation scores, presence of atrophy or intestinal metaplasia.
CONCLUSIONS: The postulated link between H. pylori infection and ischemic heart disease, if it actually exists, is unlikely to be mediated through hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422470     DOI: 10.1046/j.1523-5378.2001.00021.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  6 in total

1.  Lipid Profile in Cardiac Syndrome X: Association with Helicobacter pylori.

Authors:  Yousef Rasmi; Javad Zeynalzadeh; Alireza Shirpoor; Mirhossein Seyedmohammadzad; Reza Hajhosseini
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy.

Authors:  Birol Ozer; Ender Serin; Yuksel Gumurdulu; Fazilet Kayaselcuk; Ruksan Anarat; Gurden Gur; Kemal Kul; Mustafa Guclu; Sedat Boyacioglu
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

3.  Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency.

Authors:  Marília Campos Abreu Marino; Celso Affonso de Oliveira; Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Nelma Cristina Diogo Clementino; Leonardo França Antunes; Ricardo Araújo Oliveira; Almir Sousa Martins; Helen Lima Del Puerto; Vânia D'Almeida; Luciano Galdieri; Enio Roberto Pietra Pedroso; Mônica Maria Demas Alvares Cabral; Ana Margarida Miguel Ferreira Nogueira; Dulciene Maria Magalhães Queiroz
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

4.  Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia.

Authors:  Stefan Redéen; Anna Ryberg; Fredrik Petersson; Olle Eriksson; Katarina Nägga; Kurt Borch
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

5.  Relationship between vitamin B12, folate and homocysteine levels and H. pylori infection in patients with functional dyspepsia: a cross-section study.

Authors:  Shahid Rasool; Shahab Abid; Mohammad Perwaiz Iqbal; Naseema Mehboobali; Ghulam Haider; Wasim Jafri
Journal:  BMC Res Notes       Date:  2012-04-30

6.  No associations of Helicobacter pylori infection and gastric atrophy with plasma total homocysteine in Japanese.

Authors:  Simon Itou; Yasuyuki Goto; Takaaki Kondo; Kazuko Nishio; Sayo Kawai; Yoshiko Ishida; Mariko Naito; Nobuyuki Hamajima
Journal:  Int J Med Sci       Date:  2007-03-14       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.